MEG3 and colorectal cancer: The results showed that compared with the NC group, the tumor area in the miR-31 mimic group was significantly increased, while the tumor area in the miR-31 inhibitor group was significantly reduced (Figure 8), which indicated that MEG3 could inhibit miR-31, thereby inhibiting the development of colorectal cancer.